The treatment of idiopathic and secondary hydrarthrosis of the knee by intra-articular Rifamycin SV.
Fifty-three patients, 28 females and 25 males, aged from 21 to 68 years, affected with mono- and bilateral intermittent hydrarthrosis of the knee and of a non-inflammatory nature, were included in an open study. All of the knees involved were treated with intra-articular infiltrations with Rifamycin SV. The weekly dosage of Rifamycin SV was 500 mg; the average duration of treatment was 6 weeks. Follow-up 1 year after the end of treatment showed a decrease or regression in joint effusion in all of the knees treated.
Setti
G
G
Calciolari
C A
CA
Cimino
V
V
Zanini
A
A
Sarzi Puttini
P
P
D000328:Adult; D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006833:Hydrarthrosis / Q000188:drug therapy* / Q000209:etiology; D007270:Injections, Intra-Articular; D007719:Knee Joint; D008297:Male; D008875:Middle Aged; D012294:Rifamycins / Q000008:administration & dosage*
D012294:Rifamycins; C023808:rifamycin SV